Ziopharm Oncology reported $69.77M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Amgen AMGN:US $ 19322M 802M
AstraZeneca AZN:LN 20.92B 1.73B
Baxter International BAX:US $ 7882M 291M
Biogen BIIB:US $ 9740.9M 1825M
Bioline Rx BLRX:US $ 50.94M 6.46M
Bristol Myers Squibb BMY:US $ 30186M 65M
Corcept Therapeutics CORT:US $ 419.04M 30.82M
Curis CRIS:US $ 113.4M 12.74M
Eleven Biotherapeutics EBIO:US 180.64M 24.97M
Gilead Sciences GILD:US $ 13705M 1076M
GlaxoSmithKline GSK:LN 54.19B 25.2B
Immunogen IMGN:US $ 373.87M 82.84M
Intercept Pharmaceuticals ICPT:US $ 487.02M 9.66M
Intrexon XON:US $ 154.94M 1.69M
IONIS PHARMACEUT IONS:US $ 2253.12M 91.92M
Karyopharm Therapeutics KPTI:US $ 242.45M 34.09M
Novartis NOVN:VX 38.14B 906M
Ptc Therapeutics PTCT:US $ 694.68M 79.33M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Sangamo Biosciences SGMO:US $ 343.12M 3.06M
Tg Therapeutics TGTX:US $ 242.22M 88.75M
Verastem VSTM:US $ 113.44M 7.7M
YTE INCY:US $ 3625.84M 337.75M
Ziopharm Oncology ZIOP:US $ 69.77M 9.06M